Northern Light Venture Capital (NLVC) is a venture capital firm founded in 2005, investing at the intersection of enterprise, healthcare, and consumer technology opportunities. The firm manages over $4.5 billion in capital and has made more than 300 investments across China and the U.S.
Deal activity increased 100% year-over-year (4 deals in the last 12 months). Average disclosed round size is $38.7M (across 47 rounds with reported amounts).
Portfolio
50
Fund Size
—
Top Stage
Series B
Last 12 Mo
4
Team
HH
He HUANG
Partner
HS
Han Shen
Vice President
TY
Tuo Yu
Vice President
HW
Haowei Wang
Investment Associate
JZ
Jiagang Zhang
Analyst
WW
Wilson Wong
Portfolio Analyst
FJ
Fabio Jaco
Investor
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
71 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Vibrant Therapeutics | Series C | $61M | Jan 2026 |
 Spiro Medical | Series A | $67M | Jan 2026 |
| IiRegene Therapeutics | Series B | — | Sep 2025 |
 iRegene | Series B | — | Sep 2025 |
 VelaVigo | Seed | $60M | Jul 2025 |
 VOC.AI | Unknown | $15M | Apr 2025 |
 SanegeneBio | Series B | $110M | Jan 2025 |
 Kind Pharmaceuticals | Series C | — | Jan 2025 |
| IiRegene Therapeutics | Series B | — | Jan 2025 |
 BUD | Series B | $36.8M | May 2022 |
 Ucello Therapeutics | Series A | $25M | Feb 2022 |
| HHC Scientific | Series B | — | Sep 2021 |
 Immune Onc | Series A | $73M | Mar 2021 |
 Teon Therapeutics | Series A | $30M | Jan 2021 |
 Xiaoice | Series A | — | Jan 2021 |
| HHC Scientific | Series B | — | Jan 2021 |
| Kind Pharmaceuticals | Series B | $50M | Jan 2021 |
| YYunyinggu | Series D | — | Nov 2020 |
 Stellar Cyber | Series A | $7.1M | Mar 2020 |
 Neurophth | Series A | — | Jan 2020 |
| HHC Scientific | Series A | — | Jan 2020 |
| YYunyinggu | Series D | $46M | Jan 2020 |
 Tenafe | Series A | — | Jan 2020 |
 Huohua | Growth | $150M | Jan 2020 |
 AgotoZ | Series B | — | Nov 2019 |
Page 1 of 3
Top Co-Investors
HongShan10 shared
SIG Asia Investment8 shared
GGV Capital6 shared
Sequoia Capital6 shared
Legend Capital6 shared
IDG Capital5 shared
Oriza Ventures4 shared
Xiaomi4 shared
Legend Star4 shared
Qualcomm Ventures4 shared
Luminous Ventures4 shared
Source Code Capital3 shared
Tyche Partners3 shared
Intel Capital3 shared
Gaorong Capital3 shared
Vivo Capital3 shared
MPC3 shared
Pivotal Life Sciences3 shared
LYFE Capital3 shared
BioTrack Capital3 shared
Last updated: 7 October 2026